Illustris Pharma Compendium

Reference

Where these molecules were found

These desks found, tested, or standardised the five medicines on this folio. History explains the hold.

Kitasato Institute

5-9-1 Shirokane, Minato City, Tokyo 108-8641, Japan

The Tokyo laboratory where Satoshi Omura's soil-microbe screen produced the avermectin lead behind ivermectin.

Merck Sharp & Dohme (Rahway)

126 East Lincoln Avenue, Rahway, NJ 07065, USA

Where William Campbell's team turned avermectin into ivermectin and later launched the Mectizan donation programme.

Former Pfizer Discovery Laboratories

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

The Kent site where sildenafil was tested for angina and its erectile side effect was first taken seriously.

ICOS Corporation (historic)

22021 20th Avenue SE, Bothell, WA 98021, USA

The Washington biotech that discovered tadalafil before partnering with Eli Lilly to market Cialis.

Bayer AG Pharmaceuticals

Friedrich-Ebert-Strasse 217, 42117 Wuppertal, Germany

The German laboratories that developed vardenafil, later sold as Levitra and the orodispersible Staxyn.

Eli Lilly and Company

893 Delaware Street, Indianapolis, IN 46285, USA

Developer of fluoxetine - the SSRI, launched as Prozac, that reshaped how depression is treated.

U.S. Food and Drug Administration

10903 New Hampshire Avenue, Silver Spring, MD 20993, USA

The agency whose current prescribing information anchors every dose and warning quoted in this compendium.

World Health Organization

Avenue Appia 20, 1211 Geneva 27, Switzerland

Keeper of the Model List of Essential Medicines, which lists ivermectin and fluoxetine among core medicines.

Why the history sits on the folio

A soil screen in Tokyo explains why ivermectin is a parasite tablet, not a viral one. An angina miss in Sandwich explains why sildenafil carries a nitrate hold. A German selectivity file explains why vardenafil still asks about QT neighbours. Each slip points back at the desk that shaped it.

Illustris Pharma

Five medicines, read the slow way - from the label, not the advert.

Referenced drug notes, an evidence review shelf, and one specialist who answers the questions readers actually send.

Open the compendium